CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 16 No. 8
Pages: 1  2  3  4  
Previous
 

Current Management of Depression in Cancer Patients

By

Leonard Schwartz, LLB, LLM, MD
Resident in Psychiatry. Department of Psychiatry, University of Manitoba, Winnipeg, Manitoba, Canada
Mark Lander, MD, FRCPC
Staff Psychiatrist, Department of Psychiatry, University of Manitoba, Winnipeg, Manitoba, Canada
Harvey Max Chochinov, MD, PhD, FRCPC
Professor, Department of Psychiatry and Department of Family Medicine, Division of Palliative Care, University of Manitoba
Winnipeg, Manitoba, Canada

| August 1, 2002

Structured Cognitive Therapies

Cognitive-behavioral therapy and interpersonal therapy are systems of short-term individual and group psychotherapy that were developed specifically for the treatment of depression. Interpersonal therapy focuses on discrete manageable psychological and interpersonal issues and has shown promise in research pertaining to patients with human immunodeficiency virus (HIV) or breast cancer. Cognitive-behavioral therapy has been well established as a treatment for depression.[42] It has also been used to help with symptom management in terminally ill patients.[43] This type of intervention focuses on cognitive distortions that negatively affect mood. Improvement in such distortions often helps patients to better cope with or adapt to the vicissitudes of their illness.

Existential Psychotherapy

Existential psychotherapy involves the evaluation of one’s relationship to life, with the goal of helping patients live more fully in the moment. It is an appropriate intervention for some terminally ill persons, who confront daily choices that affect quality of life and often have questions concerning the meaning, purpose, and value of life. The way in which seriously ill patients cope influences both their emotional state and their ability to adjust. It has been demonstrated that avoidance of feelings, denial of concerns, ongoing feelings of helplessness, a stance of passive compliance, and social isolation all result in decreased quality of life, and possibly an increased risk of disease or mortality. However, open and honest expression of both feelings and thoughts corresponds to a higher quality of life and, indeed, may bolster one’s physical health.[44]

Group existential psychotherapy allows the patient to hear about the experience of others, thereby providing "lateral experience" from which the patient may consider alternative ways of understanding and action. Moreover, the perspective of other patients can challenge one’s own conclusions about life, facilitate an adjustment to one’s current circumstances, and assist in choosing actions that are truly meaningful. The group has the potential to help the patient realize that he or she is not alone, and that others have different perspectives that may bear consideration.[45,46]

The Therapeutic Life Narrative

Patient distress may not be directly related to the fear of death itself, but to concerns regarding missed opportunities, loss of autonomy and control, and regret for decisions not taken. All of these feelings may be examined through use of the psychodynamic life narrative (or life review). This form of therapy is particularly useful in patients whose previously successful adaptation has been disrupted by a crisis or a specific life event. It permits patients to understand their present experience in the context of their life history and to view their current reaction as the logical product of previous experience, rather than as an arbitrary response to illness. This may offer a reassuring sense of coherence, order, and logic in a situation that is largely beyond the patient’s individual control.

The patient is also provided with a protective therapist/physician who can offer reassurance, while attempting to capture the life narrative. The therapy gradually assumes the quality of a shared experience.[47] For example, we recently counseled an elderly gentleman with an advanced oral malignancy. This patient gained considerable comfort in being able to review his life as a successful musician. He found that the therapeutic task of sharing this history provided a context within which to understand his current existential distress and helped give him a much needed sense of life’s continued meaning and purpose.

Conclusions

Depression is a treatable condition, even in the cancer care setting. Recognizing and treating depression in severely ill patients is as important in this population as in the physically healthy, if not more so. Quality-of-life issues are never more germane than they are for patients whose lives are in jeopardy, facing the physical, psychological, and spiritual challenges that a cancer illness inevitably brings.

Screening for depression can be done simply and effectively, and treatment initiated with any of various appropriate interventions, as previously described. Moderating the level of specific neurotransmitters is only a small part of treating depression in cancer patients. The physician-patient relationship is of critical importance and should be characterized by warmth, caring, honesty, and recognition, not simply of the physical domains of patient care, but of the psychological and spiritual dimensions as well. The judicious use of medication and supportive therapies should significantly alleviate depression and enable the patient to navigate the cancer course with dignity, purpose, and the best quality of life possible.

Pages: 1  2  3  4  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



Dominique L. Musselman, MD, MS, David Lawson, MD, and Andrew H. Miller, MD


1. Massie MJ, Holland JC: Overview of normal reactions and prevalence of psychiatric disorders, in Holland JC, Rowland JH (eds): Handbook of Psycho-oncology: Psychological Care of the Patient With Cancer, pp 273-282. New York, Oxford University Press, 1989.

2. Goldman LS, Nielsen MH, Champion HC: Awareness, diagnosis, and treatment of depression. J Gen Intern Med 14:569-580, 1999.

3. Breitbart W, Rosenfeld BD, Passik SD: Interest in physician-assisted suicide among ambulatory HIV-infected patients. Am J Psychiatry 153:238-242, 1996.

4. Chochinov HM, Wilson KG, Enns M, et al: Desire for death in the terminally ill. Am J Psychiatry 152:1185-1191, 1995.

5. Breitbart W: Suicide in cancer patients. Oncology 1:49-53, 1987.

6. Derogatis LR, Morrow GR, Fetting J, et al: The prevalence of psychiatric disorders amongst cancer patients. JAMA 249:751-757, 1983.

7. Lander M, Wilson K, Chochinov HM: Depression and the dying older patient. Clin Geriatr Med 16:335-356, 2000.

8. Chochinov HM, Wilson KG, Enns M, et al: Prevalence of depression in the terminally ill: Effects of diagnostic criteria and symptom threshold judgments. Am J Psychiatry 151:537-540, 1994.

9. Bukberg J, Penman D, Holland JC: Depression in hospitalized cancer patients. Psychosom Med 46:199-212, 1984.

10. Massie MJ, Popkin MK: Depressive disorders, in Holland JC (ed): Psycho-oncology, pp 518-540. New York, Oxford University Press, 1998.

11. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994.

12. Breitbart W, Jaramillo J, Chochinov HM: Palliative and terminal care, in Holland JC (ed): Psycho-oncology, pp 437-449. New York, Oxford University Press, 1998.

13. Chochinov HM, Wilson KG, Enns M, et al: Are you depressed? Screening for depression in the terminally ill. Am J Psychiatry 154:674-676, 1997.

14. McDonald MV, Passik SD, Coyle N: Addressing the needs of the patient who requests physician-assisted suicide or euthanasia, in Chochinov HM, Breitbart W (eds): Handbook of Psychiatry in Palliative Medicine. New York, Oxford University Press, 2000.

15. Spiegel D, Bloom JR: Pain in metastatic breast cancer. Cancer 52:341-345, 1983.

16. Cohen S, Wills RA: Stress, social support, and the buffering hypothesis. Psychol Bull 98:310-357, 1985.

17. Breitbart W, Wein SE: Metabolic disorders and neurpsychiatric symptoms, in Holland JC (ed): Psycho-oncology, pp 639-653. New York, Oxford University Press, 1998.

18. Passik SD, Ricketts PL: Central nervous system tumors, in Holland JD (ed): Psycho-oncology, pp 303-313. New York, Oxford University Press, 1998.

19. Green AI, Austin CP: Psychopathology of pancreatic cancer. Psychosomatics 34:208-221, 1993.

20. Shakin EJ, Holland JC: Depression and pancreatic cancer. J Pain Symptom Manage 3:194-198, 1988.

21. Montano CB: Primary care issues related to the treatment of depression in elderly patients. J Clin Psychiatry 60(suppl 20):45-51, 1999.

22. Liu BA, Mittmann N, Knowles SR, et al: Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors; a review of spontaneous reports. Can Med Assoc J 155:519-527, 1996.

23. Hildebrand A: Drug-drug interactions with antidepressants: A focus on the elderly. Mature Medicine Canada 2:232-234, 1999.

24. Rudorfer MV, Potter WZX: A comparative review of the clinical pharmacology and therapeutic use of the "newer versus the "older" drugs. Drugs 37:713-738, 1989.

25. Sher M, Kreiger JM, Juergen S: Trazodone and priapism. Am J Psychiatry 140:1362-1364, 1983.

26. Preskorn S, Burke M: Somatic therapy for major depressive disorder: Selection of an antidepressant. J Clin Psychiatry 53:1-14, 1992.

27. Breitbart W, Chochinov HM, Passik SD: Psychiatric aspects of palliative care, in Doyle D, Hanks G, MacDonald N (eds): Oxford Textbook of Palliative Medicine, 2nd ed, pp 933-954. New York, Oxford University Press, 1997.

28. Amrein R, Martin JR, Cameron AM: Moclobemide in patients with dementia and depression. Adv Neurol 80:509-519, 1999.

29. Pies RW: Handbook of Essential Psychopharmacology. American Psychiatric Press, Washington, DC, 1998.

30. Keenan AM: Syndrome of inappropriate secretion of antidiuretic hormone in malignancy. Semin Oncol Nurs 15(3):160-167, 1999.

31. Stoudemire A, Fogel BS: Psychopharmacology in the medically ill, in Stoudemire A, Fogel BS (eds): Principles of Medical Psychiatry, pp 79-112. Orlando, Fla, Grune & Stratton, 1987.

32. Burns MM, Eisendrath SJ: Dextroampetamine treatment for depression in terminally ill patients. Psychosomatics 35:80-82, 1994.

33. Macleod AD: Methylphenidate in terminal depression. J Pain Symptom Manage 16:193-198, 1998.

34. Olin J, Masand P: Psychostimulants for depression in hospitalized cancer patients. Psychosomatics 37:57-62, 1996.

35. Bruera E, Neumann CM: The uses of psychotropics in symptom management in advanced cancer. Psycho-oncology 7:346-358, 1998.

36. Wilson K, Chochinov HM, De Faye B: Diagnosis and management of depression in palliative care, in Chochinov HM, Breitbart W (eds): Handbook of Psychiatry in Palliative Medicine. New York, Oxford University Press, 2000.

37. Chiarello RJ, Cole JO: The use of psychostimulants in general psychiatry. A reconsideration. Arch Gen Psychiatry 44:286-295, 1987.

38. Berkovitch M, Pope E, Phillips J, et al: Pemoline-associated fulminant liver failure: testing the evidence for causation. Clin Pharmacol Ther 57:696-698, 1995.

39. Massie MJ, Shakin EJ: Management of depression and anxiety in cancer patients, in Breitbart W, Holland JC (eds): Psychiatric Aspects of Symptom Management in Cancer Patients, pp 470-491. Washington, DC, American Psychiatric Press, 1993.

40. Rodin G, Gillies L: Individual psychotherapy for the patient with advanced disease, in Chochinov HM, Breitbart W (eds): Handbook of Psychiatry and Palliative Medicine. New York, Oxford University Press, 2000.

41. Spiegel D, Bloom JR, Kraemer HC: Beneficial effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888-891, 1989.

42. Beck A, Rush J, Shaw B, et al: Cognitive therapy of depression. New York, Guilford Press, 1979.

43. Turk D, Feldman C: Cognitive behavioral approach to symptom management in palliative care, in Chochinov HM, Breitbart W (eds): Handbook of Psychiatry and Palliative Medicine. New York, Oxford University Press, 2000.

44. Spiegel D, Bloom J, Yalom I: Group support for patients with metastatic cancer. Arch Gen Psychiatry 38:527-533, 1981.

45. Spira JL: Existential psychotherapy, in Chochinov HM, Breitbart W (eds): Handbook of Psychiatry in Palliative Medicine. New York, Oxford University Press, 2000.

46. Greenstein M, Breitbart W: Cancer and the experience of meaning: A group psychotherapy program for people with cancer. Am J Psychotherapy (in press).

47. Viederman M: The supportive relationship, the psychodynamic life narrative and the dying patient, in Chochinov HM, Breitbart W (eds): Handbook of Psychiatry in Palliative Medicine. New York, Oxford University Press, 2000.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 48-Year-Old Woman With Irregular Vaginal Bleeding
Brian Morse, MD1 , June 10, 2013

A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy